My Cholesterol Jumped 32 Points in a Year. Nobody Told Me Why Until I Found a 2024 Penn State Trial.

I did everything right. I walked. I cooked. I had my labs done every year like clockwork. And then, somewhere between my 53rd birthday and my 56th, the numbers started drifting — and not a single person in my life could explain why. This is what I found when I stopped waiting and started reading.

I was sitting in the parking lot of my doctor’s office, engine still running, staring at the dashboard. I had just turned 56. The appointment had taken about seven minutes. My cholesterol had jumped from 198 to 230 in a single year. My blood pressure had crept from 118/76 to 132/84. I hadn’t changed anything about how I ate or moved or slept. And my doctor had said the words I’d been quietly bracing for ever since my mother died of a heart attack at 67: “Let’s keep an eye on it. If it doesn’t come down in six months, we’ll talk about a statin.”

I sat in that parking lot for fifteen minutes. Then I picked up my phone and Googled “statin side effects.”

I am not the kind of person who panics. I work in healthcare administration. I read research papers for a living. I have watched the women in my family navigate midlife with varying degrees of grace and information. I knew the numbers mattered. I knew what came next if I didn’t do something.

What I did not know — and what nobody, in any of my seven-minute appointments since menopause, had ever explained to me — was why my numbers had suddenly started drifting at all.

I had done everything right. I walked forty-five minutes most mornings. I cooked Mediterranean most nights. I had my bloodwork done every year. And somewhere in the last three years, my cardiovascular numbers had quietly stopped behaving the way they had behaved for forty years — and not a single doctor had told me why.

This is the story of what I found when I stopped waiting for someone to explain it to me.

What I read at midnight that made the decision harder, not easier

The first thing I did was the thing every woman in my position does. I went online. I read the forums. And I found hundreds of women describing what statins had done to them.

The muscle pain was the one I expected. Women describing their shoulders and forearms feeling like they were on fire. Feeling like they’d worked out hard all day long, every day, with no recovery. Being completely knocked out on the couch after a normal conditioning workout.

But the cognitive part was what frightened me.

Brain fog. Forgetting words mid-sentence. Reaching for a name that had always been there and finding nothing. One woman — a hospital administrator, like me, someone who had been sharp her whole career — described it as “losing a layer of myself I didn’t know I had.”

I read that one twice.

I also read the posts from women who’d been on statins for fifteen years without a single complaint. I am not an anti-statin person. Statins have saved lives. I know that. But my professional identity depends on my mind being clear, and the accounts I was reading at midnight were not reassuring.

I wasn’t making a decision yet. I was trying to understand what I was weighing — what the trade-off actually looked like — before I was sitting in that office again being asked to decide.

Everything I tried that year — and why none of it moved the number

Before I found what I’m about to describe, I spent a year trying to fix the cholesterol number on my own.

I tried a menopause supplement. A friend had recommended Bonafide. I ordered it. I took it for three months. It was aimed at hot flashes, which I didn’t really have. It did nothing for the number on my lipid panel, which was the only thing I actually cared about.

I tried beetroot powder. The one with the cardiologist on the box. I mixed it into water for two weeks. It tasted like dirt someone had run through a sock. The sugar content was higher than I’d expected. After fourteen days I put the canister in the back of the pantry, where it still sits today.

I tried CoQ10. I tried fish oil. I added more leafy greens. I walked an extra mile a day. At my six-month follow-up, the cholesterol had come down two points. The blood pressure was the same.

And then I did the thing I probably should have done from the beginning, which is I stopped trying to fix the symptom and started trying to understand the mechanism.

The sentence in a clinical statement that nobody had ever said to me

I spent three months reading everything I could find. Peter Attia’s Outlive. Mary Claire Haver’s The New Menopause. Lisa Mosconi’s The Menopause Brain. I listened to podcasts on my morning walks. I read clinical abstracts over lunch. I was piecing together what my doctor had never once explained to me.

And then I found a single sentence, in a 2024 American Heart Association statement, that explained more about what was happening in my body than seven years of seven-minute appointments had.

The sentence, paraphrased: The menopause transition is associated with adverse changes in body composition, lipids, vascular function, and blood pressure — and the underlying biology of these changes is, to a meaningful degree, the loss of estrogen’s direct support of the cardiovascular system.

I read it three times. Then I put my phone down and stared at the wall.

Not because it was complicated. Because it was so simple. Because it had been there the whole time. Because nobody — not my GP, not my OB, not anyone in any appointment I’d had since menopause — had ever connected those dots for me.

My habits hadn’t changed. My body had. And the reason was a specific molecule I had never heard of, a Nobel Prize from 1998, and a clinical trial published in June 2024 that should have been on the cover of every women’s health magazine in the country.

The 1998 Nobel Prize I had never heard of

In 1998, three American researchers — Robert Furchgott, Louis Ignarro, and Ferid Murad — won the Nobel Prize in Physiology or Medicine for a discovery that sounds, on paper, almost boring.

They had identified that the body produces a tiny, short-lived molecule called nitric oxide, and that this molecule signals blood vessels to relax. When a healthy artery needs to widen — to let blood through, to carry oxygen, to keep pressure in a reasonable range — it releases nitric oxide, and the vessel relaxes.

The molecule had been hiding in the body since the first human walked the earth. But because it was so small and so short-lived, nobody had figured out what it did until the 1980s.

What I found next was an older story that made me sit down. In 1896, Alfred Nobel himself — the man who invented dynamite, the man whose name is on the prize — was prescribed nitroglycerine by his physician for chest pain. He refused to take it. He thought it absurd that the explosive compound from his own factory could also be a medicine.

He died from the very condition the nitroglycerine could have eased. A century later, the Nobel committee gave the prize to the men who finally explained what was happening inside his chest.

Two pathways. One closes at menopause. The other doesn’t.

Here is the part that made me sit at my kitchen table and stare at the wall for ten minutes.

The body has not one, but two ways to make nitric oxide.

The first pathway runs on an amino acid called arginine and an enzyme called eNOS. The body takes arginine, runs it through eNOS, and produces nitric oxide directly inside the lining of the blood vessels. That enzyme — eNOS — is activated by estrogen. When estrogen is around in normal premenopausal levels, the pathway hums along and the cardiovascular system stays well-supported.

And then, somewhere between a woman’s late forties and her mid-fifties, the ovaries stop producing estrogen. The fuel runs out. eNOS slows down. The primary nitric oxide pathway dims.

This — not my weight, not my diet, not my exercise habits, not my stress levels — is the single most under-discussed reason that postmenopausal women suddenly see their cholesterol numbers move, their blood pressure creep, their arterial stiffness increase. The pathway that was quietly protecting us for forty years has lost its main driver.

But there is a second pathway. And it does not depend on estrogen.

This second pathway takes dietary nitrate from food — the kind concentrated in beets and dark leafy greens — routes it through the saliva and the gut, and converts it stepwise into nitrite, and then into nitric oxide. The same molecule. The same protective signaling. A completely different route to get there.

Estrogen is not required. The endothelium is not required. You just need the dietary nitrate.

Researchers at the Karolinska Institute in Sweden had been mapping this second pathway since the late 1990s. The papers were technical. They sat outside the mainstream cardiology conversation for the better part of two decades. And then, in June 2024, a research team at Penn State did the trial almost nobody had bothered to do.

This is not a fitness study on twenty-something men in a gym. This is a randomized, double-blind, placebo-controlled trial. The same women received both the nitrate and the placebo, in random order, and the researchers measured what changed in their blood vessels over seven days.

The nitrate worked. The placebo didn’t.

And it worked specifically in the population nobody had bothered to study before: postmenopausal women. The very group that had lost the estrogen-dependent pathway and had been left without a clear answer for what to do next.

What this means if your doctor just said “let’s keep an eye on it”

It means your habits didn’t change. Your body did.

It means the drift in your cholesterol and your blood pressure is not a failure of willpower. It is not because you stopped trying. It is because the specific molecular pathway that has been protecting your cardiovascular system for forty years has lost its primary driver, and almost nobody in primary care has the appointment time — or, frankly, the training — to explain that to you.

It means there is a second pathway your body still has. It does not require estrogen. It runs on food.

And it means the smartest thing I could do — before my next physical, before the statin conversation, before another six months of watching and worrying — was figure out how to actually deliver that dietary nitrate, daily, in a form I would actually take, in a dose that matched the research.

Which turns out to be harder than it sounds.

Why the beetroot aisle is mostly a trap

I went looking. What I found was a category of products that were, in most cases, not built for me.

Most were powders. They tasted, as I had already discovered, like something a child would refuse. Several of the most popular brands listed the weight of the powder on the front of the bottle — “6000 mg beetroot” — but never standardized for the actual dietary nitrate content, which is the only thing that matters for the second pathway. You can have a kilogram of beetroot powder and almost no nitrate in it, depending on the soil, the variety, the processing.

Many were loaded with sugar. Several were aimed at men — bodybuilders, weekend cyclists, “pump” products with cartoon labels.

I wanted something specific. A daily capsule. No powder. No sugar. No mixing. No tongue-turns-red moment. Standardized for the dietary nitrate dose that matched the published research, not the marketing weight. Third-party tested. Made for women in midlife. Sold by a company that wasn’t embarrassing.

I found one. It is the only one I have recommended to my friends, my sister, or anyone who has asked me the same question I spent a year trying to answer.

It’s called Purevia Beetroot.

Three things made the difference for me.

First, the standardization. Purevia is built around dietary nitrate content, not powder weight. The dose aligns with the level used in postmenopausal cardiovascular research, not what looks good on a label. That alone disqualifies most of the bottles on the shelf.

Second, the format. Two capsules a day with water. No taste. No sugar. No mixing. No staining. The part I dreaded most about beetroot — the taste, the powder, the daily friction — simply isn’t part of the experience.

Third, the testing. Each batch is third-party tested for actual dietary nitrate content and for heavy-metal contamination, which is a real and under-discussed issue with root-vegetable supplements. The certificate of analysis is available on request.

How it compares to what’s on the shelf

Already convinced? See pricing →

What the women I’ve told about this have said

I have had this conversation enough times now — at kitchen tables, over text, on phone calls with friends who got the same news from their doctors — to have a small, informal sample of women who made the same decision I did. The pattern is consistent. Three of them agreed to let me share what they said, first names only.

Individual experiences will vary. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

What I would tell you if we were sitting at my kitchen table

I would tell you, first, that this is not a magic pill. There is no magic pill. The Penn State trial measured a marker of vascular function in seven days. Your body is on a longer arc than that. I have been taking Purevia for almost a year now. The women I know who are on it have been on it for anywhere from three to nine months. We have watched our next physicals, and then the ones after that.

I would tell you that supporting the second nitric oxide pathway is not a replacement for working with your doctor on the rest of your cardiovascular plan. It is not a statin. It is not a substitute for blood pressure medication if you need it. It is not hormone therapy. It is a daily, food-based way to support a specific pathway that estrogen used to support, and that the published research suggests can still be supported through diet and standardized supplementation after estrogen is gone.

And I would tell you that if you are going to try it, the dose, the standardization, and the testing are the things that actually matter — not the powder weight, not the picture on the front of the bottle.

My next lipid panel is in three weeks. I will know what it says when it arrives. What I already know is that, for the first time since menopause, I am not sitting in the parking lot after my appointments wondering what changed and why nobody is explaining it to me.

I am the one who made the move. And it started with two capsules, every morning, before coffee.